Sung-Wuk Kim
Fundador en ImmunoMet Therapeutics, Inc. .
Fortuna: 38 M $ al 30/04/2024
Perfil
Sung-Wuk Kim is the founder of ImmunoMet Therapeutics, Inc. which was founded in 2015.
He currently holds the title of Chairman at ImmunoMet Therapeutics, Inc. Dr. Kim is also currently working as the Director at Korean Drug Research Association.
In the past, he held the position of President, Chief Executive Officer & Director at HANALL BIOPHARMA Co., Ltd.
from 2011 to 2014.
Dr. Kim also served as the Chief Executive Officer at Health Prime International LLC and as a Director at Bridge Biotherapeutics, Inc. Dr. Kim completed his undergraduate degree at Yonsei University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2023 | 1 469 702 ( 2.81% ) | 38 M $ | 30/04/2024 |
Cargos activos de Sung-Wuk Kim
| Empresas | Cargo | Inicio |
|---|---|---|
| Korean Drug Research Association | Director/Miembro de la Junta | - |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Fundador | 01/11/2017 |
Antiguos cargos conocidos de Sung-Wuk Kim.
| Empresas | Cargo | Fin |
|---|---|---|
Health Prime International LLC
 Health Prime International LLC Miscellaneous Commercial ServicesCommercial Services Health Prime International LLC engages in the supply of outsourced medical billing services. It offers PrimeEHR, PrimeQuality, PrimeTranscription, PrimeContact, PrimeConsult, PrimeSmartCharge, and PrimeMarketing. The company was founded by Vinod K. Shah in 2004 and is headquartered in National Harbor, MD. | Director Ejecutivo | - |
| BRIDGE BIOTHERAPEUTICS, INC. | Director/Miembro de la Junta | - |
| HANALL BIOPHARMA CO., LTD. | Director Ejecutivo | - |
Formación de Sung-Wuk Kim.
| Yonsei University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| HANALL BIOPHARMA CO., LTD. | Health Technology |
| BRIDGE BIOTHERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
| Korean Drug Research Association | |
Health Prime International LLC
Health Prime International LLC Miscellaneous Commercial ServicesCommercial Services Health Prime International LLC engages in the supply of outsourced medical billing services. It offers PrimeEHR, PrimeQuality, PrimeTranscription, PrimeContact, PrimeConsult, PrimeSmartCharge, and PrimeMarketing. The company was founded by Vinod K. Shah in 2004 and is headquartered in National Harbor, MD. | Commercial Services |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Sung-Wuk Kim
